BACE1 and Alzheimer disease: HYP (20, 40, 80 mg/kg) has been shown to exert neuroprotective effects in cellular or APP/PSEN1 double transgenic AD mouse models by anti-Aβ aggregation, BACE1 inhibition, reduction of Aβ plaques and GFAP levels in cortex and hippocampus.